Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Present And Forecasted Size Of The Antivirals Market?

There has been significant expansion of the antivirals market size in past times. Its value is predicted to rise from $106.64 billion in 2024 to $114.4 billion in 2025, registering a compound annual growth rate (CAGR) of 7.3%. The historical period’s growth can be linked to the prevalence of viral diseases, public health worries, lapses in patent rights, and efforts taken by the government.

Over the upcoming years, the antivirals market is anticipated to witness robust growth, expanding to “$151.54 billion by 2029 with a compound annual growth rate (CAGR) of 7.3%. The increase predicted for the forecast period is credited to the rise of new viral threats and worldwide health initiatives. The forecast period is set to be marked by significant trends such as technological progression, the rise of telemedicine and digital health, and the growth of personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Which Key Factors Are Fueling Growth In The Antivirals Market?

The rise in influenza cases is expected to boost the antiviral market’s expansion. Influenza, commonly known as the flu, is an extremely infectious viral respiratory disorder caused by the influenza virus, which impacts the nose, throat, and lungs. Antivirals, intended to prevent the growth and dissemination of the influenza virus inside the body, are utilized to treat this disease. For example, the US-based health agency, the Centers for Disease Control and Prevention, reported in October 2022 that, during the 2021-2022 season, there were 9 million instances of flu illnesses, 4 million flu-associated medical consultations, 100,000 flu-related hospitalizations, and 5,000 flu fatalities. Consequently, the escalating rate of influenza is fueling the antiviral market’s growth.

What Are The Key Segment Trends Observed In The Antivirals Market?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Which Disruptive Trends Are Driving Change Across The Antivirals Market?

Key players in the antiviral market are shifting their focus towards the creation of novel therapies such as oral antiviral treatment. This pivot aims at enhancing patient adherence, improving accessibility, lowering healthcare expenses, and offering more suitable and effective alternatives for the management of viral infections. Oral antiviral therapy means medication taken orally to combat viral infections. These treatments function by obstructing the replication or dissemination of viruses within the body, thus minimizing the intensity and duration of the infection. For example, in May 2023, Pfizer, a pharmaceutical company based in the United States, announced the approval of Paxlovid, the first-ever oral antiviral treatment for adults with COVID-19, approved by the Food and Drug Administration, a U.S. government agency. This approval carries noteworthy significance as it furnishes a fresh therapeutic alternative for managing COVID-19, particularly in a scenario where the pandemic is evolving into an endemic phase. Paxlovid is specifically designated for adults with mild to moderate COVID-19 who are at an elevated risk of escalating to a severe stage, including hospitalization or death.

Who Are The Major Stakeholders Operating In The Antivirals Market?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Regional Factors Are Accelerating Growth In The Antivirals Market?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model